Showing results (2501-2510 of 2,775) with videos related to

Sort By:
Pageof 278
BMC Public Health|January 16, 2024
Community cervical cancer screening and precancer risk in women living with HIV in Jos NigeriaF A Magaji, M I Mashor, S A Anzaku, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2024
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretrovirusesTakafumi Shichijo, Jun-Ichirou Yasunaga, Kei Sato, et al.
Contemporary Clinical Trials|December 10, 2022
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response (SCEPTER), a pragmatic trial for conservative chronic low back pain treatmentJ David Clark, Matthew J Bair, Ilana Belitskaya-Lévy, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
Human pluripotent stem cell-derived neural constructs for predicting neural toxicityMichael P Schwartz, Zhonggang Hou, Nicholas E Propson, et al.
Nature|August 19, 2005
ERM is required for transcriptional control of the spermatogonial stem cell nicheChen Chen, Wenjun Ouyang, Vadim Grigura, et al.
Infectious Agents and Cancer|April 30, 2025
Analytical performance of the ScreenFire HPV RS Zebra BioDome assay on four different qPCR platformsJun Wang, Godwin Imade, Alani S Akanmu, et al.
Plos Neglected Tropical Diseases|March 8, 2013
Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donorsAntonio L Ribeiro, Ester C Sabino, Milena S Marcolino, et al.
The EMBO Journal|November 12, 2017
Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clientsMark R Woodford, Rebecca A Sager, Elijah Marris, et al.
Nature|June 22, 2022
Ablation of cDC2 development by triple mutations within the Zeb2 enhancerTian-Tian Liu, Sunkyung Kim, Pritesh Desai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancerW Xie, P Ravi, M Buyse, et al.
Pageof 278